Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...

CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

Why the end of Neighbours is bad news for Australian TV – and viewers ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...

More than half of large employers plan to scale back health care benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...

The luxury group's jewelry division, which houses heavyweight brands Cartier and Van Cleef & Arpels, saw an 11% rise in sales. The Jeep parent said it would discontinue its hydrogen fuel-cell ...

Renault slashed its financial targets for the year, citing a worsening automotive market as the group faces stiff competition from rivals, and elevated finance chief Duncan Minto to interim CEO. J.B.

This is the second CVS store to close in Billings this year, and it's also the last store with a wine room.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...

Zepbound users face new hurdles as CVS drops the drug Eli Lilly's Zepbound faces insurance hurdles as coverage changes could spike out-of-pocket costs for millions relying on weight loss medications.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay programs at $499 monthly ...